Tasigna is a prescription drug used for the treatment of Philadelphia chromosome positive chronic myeloid leukemia (CML) in adults and children who are at least 1 year old. To buy Tasigna or to know its price contact 3S Corporation.
Manufacturer : Novartis Pharmaceuticals Corporation
Strengths available : 150mg , 200mg
Form : Capsules
Dosage : Recommended Dosage – Tasigna should be taken twice daily at approximately 12-hour intervals and must be taken on an empty stomach. No food should be consumed for at least 2 hours before the dose is taken and for at least 1 hour after the dose is taken. Advise patients to swallow the capsules whole with water.
For patients who are unable to swallow capsules, the contents of each capsule may be dispersed in 1 teaspoon of applesauce (puréed apple). The mixture should be taken immediately (within 15 minutes) and should not be stored for future use.
Tasigna may be given in combination with hematopoietic growth factors such as erythropoietin or G-CSF if clinically indicated. Tasigna may be given with hydroxyurea or anagrelide if clinically indicated.
Dosage in Adult Patients with Newly Diagnosed Ph+ CML-CP-The recommended dose of Tasigna is 300 mg orally twice daily.
Dosage in Adult Patients with Resistant or Intolerant Ph+ CML-CP and CML-AP-The recommended dose of Tasigna is 400 mg orally twice daily.
Dosage in Pediatric Patients with Newly Diagnosed Ph+ CML-CP or Resistant or Intolerant Ph+ CML-CP-The recommended dose of Tasigna for pediatric patients is 230 mg/m2 orally twice daily, rounded to the nearest 50 mg dose (to a maximum single dose of 400 mg).
Storage : Do not store above 30°C.
Is the medicine FDA approved : Yes
Date of Approval : 29th October, 2007
Common side effects are diarrhea, difficulty with moving, back pain, burning, itching and pain in hairy areas, lack or loss of strength, joint pain or swelling, pain in arms or legs, muscle spasms and pus at the root of the hair.